| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/27/2001 | CA2402763A1 Proteases |
| 09/27/2001 | CA2402747A1 G-protein associated molecules |
| 09/27/2001 | CA2402722A1 Sperm factor oscillogenin |
| 09/27/2001 | CA2402596A1 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | CA2402380A1 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | CA2401887A1 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | CA2400638A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | CA2374073A1 Novel polypeptides and nucleic acids encoding same |
| 09/26/2001 | EP1136556A1 Multivalent antigen-binding proteins |
| 09/26/2001 | EP1136548A1 Novel trypsin family serine proteases |
| 09/26/2001 | EP1136547A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof |
| 09/26/2001 | EP1136504A1 Receptor for Latrotoxin from insects |
| 09/26/2001 | EP1136502A1 Insect ligand-gated anion channels |
| 09/26/2001 | EP1136501A2 Receptors for peptides from insect origin |
| 09/26/2001 | EP1136500A2 Seroreactive regions from the HPV proteins E1 and E2 |
| 09/26/2001 | EP1135688A2 Methods and compositions useful for targeting activated vitronectin receptor alpha(nu)-beta(3) |
| 09/26/2001 | EP1135687A1 An immunoassay for the determination of transmissible spongiform encephalopathies in mammals |
| 09/26/2001 | EP1135685A2 Methods for quantitation of hla-dr and cd11b |
| 09/26/2001 | EP1135511A1 Phosphonate metabolizing plants |
| 09/26/2001 | EP1135509A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135507A1 Fruit flavour related genes and use thereof |
| 09/26/2001 | EP1135504A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 09/26/2001 | EP1135503A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
| 09/26/2001 | EP1135501A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 09/26/2001 | EP1135500A1 Control of flowering |
| 09/26/2001 | EP1135498A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 09/26/2001 | EP1135497A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 09/26/2001 | EP1135496A2 Ucp5 |
| 09/26/2001 | EP1135495A2 Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
| 09/26/2001 | EP1135494A2 Neuron-associated proteins |
| 09/26/2001 | EP1135491A2 Methods and compositions for inhibiting neoplastic cell growth |
| 09/26/2001 | EP1135490A1 Human vanilloid receptors and their uses |
| 09/26/2001 | EP1135489A1 Pth1r and pth3r receptors |
| 09/26/2001 | EP1135488A1 Human semaphorin 6a-1 (sema6a-1), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
| 09/26/2001 | EP1135485A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 09/26/2001 | EP1135484A2 Gtpase associated proteins |
| 09/26/2001 | EP1135483A2 Cytokine signal regulators |
| 09/26/2001 | EP1135477A1 Humanized monoclonal antibodies |
| 09/26/2001 | EP1135467A1 Psca: prostate stem cell antigen and uses thereof |
| 09/26/2001 | EP1135416A2 Tumor specific human monoclonal antibodies and methods of use |
| 09/26/2001 | EP1135415A1 Humanized antibodies to gamma-interferon |
| 09/26/2001 | EP1135412A2 Tumor necrosis factor receptor homologue-1 (trh1) |
| 09/26/2001 | EP1135407A1 Ring finger protein zapop3 |
| 09/26/2001 | EP1135166A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/26/2001 | EP1135160A2 Boron neutron capture therapy using pre-targeting methods |
| 09/26/2001 | EP1135158A2 Enhanced vaccines |
| 09/26/2001 | EP1135153A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 09/26/2001 | EP0859792B1 Tryptase polyclonal antibody and purification method for use in human tryptase immunoassay |
| 09/26/2001 | EP0834145B1 A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions |
| 09/26/2001 | EP0804581B1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
| 09/26/2001 | EP0771325B1 Process for modifying the stability of antibodies |
| 09/26/2001 | EP0767796B1 Chemotactic protein |
| 09/26/2001 | EP0495910B1 Production and use of human nm23-h2 protein and antibodies therefor |
| 09/26/2001 | CN1314917A Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinase |
| 09/26/2001 | CN1314487A New polypeptide-human protein tyrosine phosphatase-epsilon-12 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314486A New polypeptide-human histidinacyl-tRNA sythetase 85 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314476A New polypeptide-human phosphatidylinositol 3 (PtdIns 3)-kinase 36 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314475A New polypeptide-human tyrosinase 10 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314471A New human gamma-butyrobetaine hydroxylase and its coding sequence |
| 09/26/2001 | CN1314468A Relative new gene of DiGeorge syndrome and its protein |
| 09/26/2001 | CN1314414A New activated T cell surface antigen of molecular weight 140 KDa |
| 09/26/2001 | CN1314413A New polypeptide-human nucleotide recection repair protein 14 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314410A New polypeptide-human conjugated adhesion molecule 9 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314399A New polypeptide-human regulative transcription factor 14 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314395A New polypeptide-human prostatic specific membrane anti-body protein 9 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314388A New polypeptide-human prostatic specific membrane anti-body protein 12 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314373A New polypeptide-human interleukin enhanced binding factor 1-13 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314372A New polypeptide-human zinc finger protein 30 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314369A New polypeptide-human phosphatidyl choline transport protein 16 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314368A New polypeptide-human zinc finger protein 53 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314366A New polypeptide-human CHS protein 24 and polynucleotide for coding such polypeptide |
| 09/26/2001 | CN1314363A Purification of human myocardial troponin I and proparation of monoclonal anti-body thereof and its quick detecting method |
| 09/26/2001 | CN1071579C Process for preparing anti-body conjugates for treamtent of tumor disease |
| 09/25/2001 | US6294661 Compounds |
| 09/25/2001 | US6294660 Nucleic acids encoding B7-1 and B7-2 molecules |
| 09/25/2001 | US6294654 Modified immunoglobulin molecule incorporating an antigen in a non-CDR loop region |
| 09/25/2001 | US6294653 RNA binding protein and binding site useful for expression of recombinant molecules |
| 09/25/2001 | US6294652 Response regulator |
| 09/25/2001 | US6294651 An isolated protein; therapy for immunocompromised patients, treatment of mycoses; diagnostic drugs |
| 09/25/2001 | US6294383 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 09/25/2001 | US6294381 Enriching for cd11c negative dendritic cells by contacting with anti-cd123 antibody, then selecting positive cells |
| 09/25/2001 | US6294353 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 09/25/2001 | US6294348 Detection of moduators of signal transduction; incubate sample with modulator and monitor sample for adjustment in signal transduction |
| 09/25/2001 | US6294340 Method of binding material to the β-amyloid peptide |
| 09/25/2001 | US6294321 Simple method by contacting sample with beta-(1-3)-glucan binding agent to form complexes, then detecting complexes as indication of infection |
| 09/25/2001 | US6294177 Particularly useful in the treatment of mastitis. |
| 09/25/2001 | US6294175 Compounds |
| 09/25/2001 | US6294174 Peptides immunologically related to known viral protein |
| 09/25/2001 | US6294173 Methods for treating a tumor containing fibrin using a fibrin specific monoclonal antibody and compositions used therein |
| 09/25/2001 | US6294172 Monoclonal antibodies with specificity for membrane-associated antigens |
| 09/25/2001 | US6294171 Methods for treating disease states comprising administration of low levels of antibodies |
| 09/25/2001 | US6294169 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
| 09/25/2001 | US6294167 Treating residual tumor cells, transplanting bone marrow cells |
| 09/25/2001 | CA2110058C Hepatitis c virus (hcv) polypeptides |
| 09/21/2001 | WO2001068118A1 Method for reducing allergen-induced airway hyperresponsiveness |
| 09/21/2001 | CA2403690A1 Method for reducing allergen-induced airway hyperresponsiveness |
| 09/20/2001 | WO2001069253A2 3d model of an fc epsilon receptor alpha chain-ige fc region complex |
| 09/20/2001 | WO2001068880A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 09/20/2001 | WO2001068862A1 Insulin homolog polypeptide zins4 |
| 09/20/2001 | WO2001068861A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |